Clinical and Experimental Hypertension

Papers
(The H4-Index of Clinical and Experimental Hypertension is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin–angiotensin system inhibitors44
Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?41
Systemic immune-inflammation index is associated with increased carotid intima-media thickness in hypertensive patients29
Nrf2 inhibition induces oxidative stress, renal inflammation and hypertension in mice28
Gut microbiota and hypertension: association, mechanisms and treatment22
Survival rate in hypertensive patients with COVID-1920
The investigation of antioxidant and anti-inflammatory potentials of apitherapeutic agents on heart tissues in nitric oxide synthase inhibited rats via Nω-nitro-L-arginine methyl ester19
Effects of blackcurrant extract on arterial functions in older adults: A randomized, double-blind, placebo-controlled, crossover trial18
Association between the combined fat mass and fat-free mass index and hypertension: The Tohoku Medical Megabank Community-based Cohort Study15
Anxiety and depression levels in Covid-19 disease and their relation to hypertension14
Association of red blood cell distribution width, systemic-immune-inflammation index and poor cardiovascular outcomes in patients with newly diagnosed hypertension14
Association between composite dietary antioxidant index and hypertension: insights from NHANES14
Urotensin-II, oxidative stress, and inflammation increase in hypertensive and resistant hypertensive patients13
Exaggerated blood pressure response to exercise is associated with subclinical vascular impairment in healthy normotensive individuals13
0.11757397651672